Source:http://linkedlifedata.com/resource/pubmed/id/14615698
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4 Pt 1
|
pubmed:dateCreated |
2003-11-17
|
pubmed:abstractText |
Personality disorders and particularly antisocial personality disorders (APD) are quite frequent in opioid-dependent subjects. They show various personality traits: high neuroticism, high impulsivity, higher extraversion than the general population. Previous studies have reported that some but not all personality traits improved with treatment. In a previous study, we found a low rate of APD in a French population of opioid-dependent subjects. For this reason, we evaluated personality traits at intake and during maintenance treatment with methadone. Methods - The form A of the Eysenck Personality Inventory (EPI) was given to opioid addicts at intake and after 6 and 12 months of methadone treatment. Results - 134 subjects (96 males and 38 females) took the test at intake, 60 completed 12 months of treatment. After 12 months, the EPI Neuroticism (N) and the Extraversion-introversion (E) scale scores decreased significantly. The N score improved in the first 6 months, while the E score improved only during the second 6 months of treatment. Compared to a reference group of French normal controls, male and female opioid addicts showed high N and E scores. Demographic data and EPI scores of patients who stayed in treatment for 12 months did not differ significantly from those of dropouts (n=23). Patients with a history of suicide attempts (SA) started to use heroin at an earlier age and they showed a higher E score and a tendency for a higher N score at intake. Discussion - The two personality dimensions of the EPI changed during MMT, and the N score converged towards the score of normal controls. Opioid addicts differ from normal controls mostly in their N score. The EPI did not help to differentiate 12-month completers from dropouts. Higher E scores in patients with an SA history might reflect a higher impulsivity, which has been linked to suicidality in other patient groups.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0013-7006
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
285-92
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14615698-Adult,
pubmed-meshheading:14615698-Drug Administration Schedule,
pubmed-meshheading:14615698-Female,
pubmed-meshheading:14615698-Humans,
pubmed-meshheading:14615698-Male,
pubmed-meshheading:14615698-Methadone,
pubmed-meshheading:14615698-Narcotics,
pubmed-meshheading:14615698-Opioid-Related Disorders,
pubmed-meshheading:14615698-Personality Disorders,
pubmed-meshheading:14615698-Personality Inventory,
pubmed-meshheading:14615698-Severity of Illness Index,
pubmed-meshheading:14615698-Suicide, Attempted
|
pubmed:articleTitle |
[Personality changes in opioid-dependent subjects in a methadone maintenance treatment program].
|
pubmed:affiliation |
Formation et Recherche en Neurosciences Appliquées à la Psychiatrie.
|
pubmed:publicationType |
Journal Article,
English Abstract
|